S405 250 (Fosrenol 250 mg)

Generic Name: lanthanum carbonate

Pill imprint S405 250 has been identified as Fosrenol 250 mg.

Fosrenol is used in the treatment of hyperphosphatemia of renal failure and belongs to the drug class phosphate binders. Risk cannot be ruled out during pregnancy. Fosrenol 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for S405 250

Fosrenol 250 mg S405  250
Fosrenol
Generic Name:
lanthanum carbonate
Imprint:
S405 250
Strength:
250 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Phosphate binders
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Shire US Inc.
National Drug Code (NDC):
54092-0247
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54092-0251 Shire US Inc

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)